Outcome by Treatment Protocols and by Cytogenetic Risk Groups
| . | Unfavorable . | Miscellaneous . | Normal . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| <8811 (n = 22) . | ≥8811 (n = 78) . | P . | <8811 (n = 20) . | ≥8811 (n = 57) . | P . | <8811 (n = 25) . | ≥8811 (n = 54) . | P . | |
| CR rate (%) | 68 | 82 | .23 | 50 | 88 | .001 | 68 | 89 | .03 |
| Median DFS (yr) | 0.6 | 0.9 | .07 | 0.8 | >3.5 | .04 | 1.7 | 2.4 | .65 |
| Median survival (yr) | 1.4 | 1.1 | .53 | 1.0 | >3.1 | .004 | 2.5 | 3.2 | .51 |
| Probability of CCR at 5 yr (95% CI) | .00 (−) | .14 (.05-.30) | .30 (.12-.57) | .57 (.40-.73) | .35 (.16-.61) | .39 (.25-.56) | |||
| Probability of survival at 5 yr (95% CI) | .05 (.01-.15) | .15 (.07-.30) | .25 (.12-.45) | .57 (.41-.72) | .26 (.13-.47) | .43 (.29-.58) | |||
| . | Unfavorable . | Miscellaneous . | Normal . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| <8811 (n = 22) . | ≥8811 (n = 78) . | P . | <8811 (n = 20) . | ≥8811 (n = 57) . | P . | <8811 (n = 25) . | ≥8811 (n = 54) . | P . | |
| CR rate (%) | 68 | 82 | .23 | 50 | 88 | .001 | 68 | 89 | .03 |
| Median DFS (yr) | 0.6 | 0.9 | .07 | 0.8 | >3.5 | .04 | 1.7 | 2.4 | .65 |
| Median survival (yr) | 1.4 | 1.1 | .53 | 1.0 | >3.1 | .004 | 2.5 | 3.2 | .51 |
| Probability of CCR at 5 yr (95% CI) | .00 (−) | .14 (.05-.30) | .30 (.12-.57) | .57 (.40-.73) | .35 (.16-.61) | .39 (.25-.56) | |||
| Probability of survival at 5 yr (95% CI) | .05 (.01-.15) | .15 (.07-.30) | .25 (.12-.45) | .57 (.41-.72) | .26 (.13-.47) | .43 (.29-.58) | |||
Abbreviation: CI, confidence interval.